Publications

Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults.

Etuwewe, OM; Swann, N; Hollingshead, S; Tolmie, H; Zijlstra, EE; Faragher, B; FRENCH, N; Gordon, SB;

2009

Vaccine, (2009).27 29 10.1016/j.vaccine.2009.04.026.

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.

OWUSU-AGYEI, S; Ansong, D; Asante, K; Kwarteng Owusu, S; Owusu, R; Wireko Brobby, NA; DOSOO, D; Osei Akoto, A; Osei-Kwakye, K; Adjei, EA; Boahen, KO; Sylverken, J; Adjei, G; Sambian, D; Apanga, S; Kayan, K; Vekemans, J; Ofori-Anyinam, O; Leach, A; Lievens, M; Demoitie, M-A; Dubois, M-C; Cohen, J; Ballou, WR; Savarese, B; ... Evans, J.

2009

PloS one, (2009).4 10 10.1371/journal.pone.0007302.

Prospective surveillance of streptococcal sore throat in a tropical country.

Steer, AC; Jenney, AW J; Kado, J; Good, MF; Batzloff, M; Magor, G; Ritika, R; MULHOLLAND, KE; Carapetis, JR;

2009

The Pediatric infectious disease journal, (2009).28 6 10.1097/INF.0b013e318194b2af.

Introduction of rotavirus vaccine.

Griffiths, UK; CLARK, AD; Mulholland, KM;

2009

BMJ (Clinical research ed.), (2009).339, 10.1136/bmj.b3482.

Reduction of meningitis and impact on under-5 pneumonia after introducing the Hib vaccine in the Kingdom of Tonga.

Russell, FM; Fakakovi, T; Paasi, S; Ika, A; MULHOLLAND, EK;

2009

Annals of tropical paediatrics, (2009).29 2 10.1179/146532809X440725.

Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection.

Mueller, I; Moorthy, VS; Brown, GV; SMITH, PG; Alonso, P; Genton, B; WHO Malaria Vaccine Advisory Committee (MALVAC),;

2009

Vaccine, (2009).27 41 10.1016/j.vaccine.2009.07.018.

On the relationship between meningococcal transmission dynamics and disease: remarks on humoral immunity.

Guzzetta, G; Manfredi, P; Gasparini, R; Panatto, D; EDMUNDS, WJ;

2009

Vaccine, (2009).27 25-26 10.1016/j.vaccine.2009.01.092.

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine.

Russell, FM; Balloch, A; Tang, ML K; Carapetis, JR; Licciardi, P; Nelson, J; Jenney, AW J; Tikoduadua, L; Waqatakirewa, L; Pryor, J; Byrnes, GB; Cheung, YB; MULHOLLAND, EK;

2009

Vaccine, (2009).27 41 10.1016/j.vaccine.2009.06.098.

Clinical laboratory practices for the detection of rotavirus in England and Wales: can surveillance based on routine laboratory testing data be used to evaluate the impact of vaccination?.

ATCHISON, CJ; Lopman, BA; Harris, CJ; Tam, CC; Iturriza Gómara, M; Gray, JJ;

2009

Euro surveillance, (2009).14 20 10.2807/ese.14.20.19217-en.

Humoral and cell-mediated immunity to MSP3 peptides in adults immunized with MSP3 in malaria endemic area, Burkina Faso.

Nebie, I; Diarra, A; Ouedraogo, A; Tiono, AB; Konate, AT; Gansane, A; Soulama, I; COUSENS, S; Leroy, O; Sirima, SB;

2009

Parasite immunology, (2009).31 8 10.1111/j.1365-3024.2009.01130.x.